Previously, other weight-loss drugs have been removed from the market for similar reasons [10], and regulators worldwide are currently reviewing safety data on GLP-1RA [11,12,13]
Lifestyle & Performance Applications Off-label use: Beyond clinical therapy, PT-141 is used in performance and wellness communities for its ability to increase libido and intimacy
10.3390/ijms23179826
Disproportionality analysis Disproportionality analysis represents a fundamental methodology in pharmacovigilance and drug safety surveillance, designed to identify potential safety signals through the detection of statistical imbalances in adverse drug reaction (ADR) reporting patterns
Your provider will answer your questions, assess your needs, and ask about your current weight, medical history, family health background, and personal goals to create a treatment plan tailored just for you
Shin HS, See HJ, Jung SY, et al